Vuento MH - Search Results

1

Evaluation of ovarian findings in asymptomatic postmenopausal women with color Doppler ultrasound.

Vuento MH, Pirhonen JP, Mäkinen JI, Laippala PJ, Grönroos M, Salmi TA. Vuento MH, et al. Cancer. 1995 Oct 1;76(7):1214-8. doi: 10.1002/1097-0142(19951001)76:7<1214::aid-cncr2820760718>3.0.co;2-5. Cancer. 1995. PMID: 8630900 Clinical Trial.

2

Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension.

Grönroos M, Salmi TA, Vuento MH, Jalava EA, Tyrkkö JE, Maatela JI, Aromaa AR, Siegberg R, Savolainen ER, Kauraniemi TV. Grönroos M, et al. Among authors: vuento mh. Cancer. 1993 Feb 15;71(4):1279-82. doi: 10.1002/1097-0142(19930215)71:4<1279::aid-cncr2820710418>3.0.co;2-4. Cancer. 1993. PMID: 8435805

3

Endometrial fluid accumulation in asymptomatic postmenopausal women.

Vuento MH, Pirhonen JP, Mäkinen JI, Tyrkkö JE, Laippala PJ, Grönroos M, Salmi TA. Vuento MH, et al. Ultrasound Obstet Gynecol. 1996 Jul;8(1):37-41. doi: 10.1046/j.1469-0705.1996.08010037.x. Ultrasound Obstet Gynecol. 1996. PMID: 8843618 Free article.

4

Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.

Vuento MH, Stenman UH, Pirhonen JP, Mäkinen JI, Laippala PJ, Salmi TA. Vuento MH, et al. Gynecol Oncol. 1997 Jan;64(1):141-6. doi: 10.1006/gyno.1996.4545. Gynecol Oncol. 1997. PMID: 8995563 Clinical Trial.

5

Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and colour Doppler sonography.

Vuento MH, Pirhonen JP, Mäkinen JI, Tyrkkö JE, Laippala PJ, Grönroos M, Salmi TA. Vuento MH, et al. Br J Obstet Gynaecol. 1999 Jan;106(1):14-20. doi: 10.1111/j.1471-0528.1999.tb08079.x. Br J Obstet Gynaecol. 1999. PMID: 10426254 Clinical Trial.

6

Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma.

Vuento M, Salmi T, Klemi P, Grénman S. Vuento M, et al. Anticancer Res. 2007 Mar-Apr;27(2):1015-8. Anticancer Res. 2007. PMID: 17465236 Free article.

7

Long-term effects of hormone replacement therapy on the uterus and on uterine circulation.

Pirhonen JP, Vuento MH, Mäkinen JI, Salmi TA. Pirhonen JP, et al. Among authors: vuento mh. Am J Obstet Gynecol. 1993 Feb;168(2):620-30. doi: 10.1016/0002-9378(93)90506-e. Am J Obstet Gynecol. 1993. PMID: 8438940

8

The risk of endometrial cancer in diabetic and hypertensive patients: a nationwide record-linkage study in Finland.

Maatela J, Aromaa A, Salmi T, Pohja M, Vuento M, Grönroos M. Maatela J, et al. Ann Chir Gynaecol Suppl. 1994;208:20-4. Ann Chir Gynaecol Suppl. 1994. PMID: 8092764

9

Hematological toxicity of salvage treatment after high-dose chemotherapy and conventional chemotherapy of ovarian cancer.

Vuento MH, Salmi TA, Remes KJ, Grénman SE. Vuento MH, et al. Anticancer Res. 2002 Mar-Apr;22(2B):1151-5. Anticancer Res. 2002. PMID: 12168916

10

A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: the Finnish Ovarian Cancer (FINOVA) study.

Grénman S, Wiklund T, Jalkanen J, Kuoppala T, Mäenpää J, Kuronen A, Leminen A, Puistola U, Vuolo-Merilä P, Salmi T, Vuento M, Yliskoski M, Itälä M, Helenius H, Joensuu H, Lehtovirta P. Grénman S, et al. Eur J Cancer. 2006 Sep;42(14):2196-9. doi: 10.1016/j.ejca.2006.03.021. Epub 2006 Aug 8. Eur J Cancer. 2006. PMID: 16893642 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page